Brief: Medrx commences phase I clinical trial for spastic paralysis treatment plasters in U.S.
Brief: Medrx receives notice on patent assessment for microneedles and microneedle arrays in China
2016 6-month parent forecast
2016 6-month group forecast
Table: Medrx -2016 parent forecast
Table: Medrx -6-MTH group results
Brief: Medrx issues bonds worth 631.8 mln yen
Brief: Medrx to issue convertible bonds with warrants to raise 631.8 mln yen
Brief: Medrx announces phase I clinical trials result of MRX-5LBT in US
Table: Medrx -Q1 group results
Table: Medrx -2015 group results
Table: Medrx -2015 parent results
Table: Medrx -9-MTH group results